Impact of the UK lockdown on people at risk of COPD.
File(s) 00358-2021.full.pdf (148.9 KB)
Published version
Author(s)
Type
Journal Article
Date Issued
2021-10
Date Acceptance
2021-09-29
Citation
ERJ Open Research, 2021, 7 (4), pp.1-4
ISSN
2312-0541
Publisher
European Respiratory Society
Start Page
1
End Page
4
Journal / Book Title
ERJ Open Research
Volume
7
Issue
4
Copyright Statement
©The authors 2021
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
License URL
Sponsor
GlaxoSmithKline Services Unlimited
Novartis Pharma Ag
Boehringer Ingelheim Pharma Gmbh & Co KG
AstraZeneca UK Limited
Chiesi Farmaceutici S.P.A
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/34820444
PII: 00358-2021
Grant Number
PO6600145677
C028-3002979185
PO 6101188364
PO 7100013120
PO 4500248634
Publication Status
Published
Coverage Spatial
England
Date Publish Online
2021-11-22
